Manuscripts
Showing 1554 manuscripts.
Birth Weight and Preterm Delivery Outcomes of Perinatally vs Nonperinatally Human Immunodeficiency Virus-Infected Pregnant Women in the United States: Results From the PHACS SMARTT Study and IMPAACT P1025 Protocol
Citation
Paige L Williams, Mitchell E Geffner, Elizabeth G Livingston, Rhonda S Sperling, Kunjal Patel, Arlene D Bardequez, Sandra K Burchett, Nahida Chakhtoura, Gwendolyn B Scott, Russell B Van Dyke, Elaine J Abrams, Pediatric HIV/AIDS Cohort Study and the International Maternal Pediatric Adolescent AIDS Clinical Trials P1025 Protocol, Jennifer Jao, Deborah Kacanek. Birth Weight and Preterm Delivery Outcomes of Perinatally vs Nonperinatally Human Immunodeficiency Virus-Infected Pregnant Women in the United States: Results From the PHACS SMARTT Study and IMPAACT P1025 Protocol. Clinical Infectious Diseases. 2017. 65: 982-989. PMID: 28575201Year
2017
Journal
Clinical Infectious Diseases
Study
P1025
Decline in CD4 T lymphocytes with monotherapy bridging strategy for non-adherent adolescents living with HIV infection: Results of the IMPAACT P1094 randomized trial.
Citation
EJ McFarland, GK Siberry, AJ Melvin, AA Wiznia, L Fairlie, S Boyd, P Harding, HML Spiegel, EJ Abrams, VJ Carey, P1094 Study Team, AL Agwu, MG Warshaw. Decline in CD4 T lymphocytes with monotherapy bridging strategy for non-adherent adolescents living with HIV infection: Results of the IMPAACT P1094 randomized trial.. PLoS One. 2017. 12: e0178075. PMID: 28604824Year
2017
Journal
PLoS One
Study
P1094
Cytomegalovirus Urinary Shedding in HIV-infected Pregnant Women and Congenital
Cytomegalovirus Infection
Citation
B Ank, J Move, DH Watts, K Nielsen-Saines, LM Mofenson, NICHD HPTN 040, JH Pilotto, E Joao, B Santos, R Fonseca, R Kreitchmann, J Pinto, MM Mussi-Pinhata, G Gray, G Theron, MG Morgado, YJ Bryson, K Adachi, VG Veloso, J Xu, JD Klausner. Cytomegalovirus Urinary Shedding in HIV-infected Pregnant Women and Congenital Cytomegalovirus Infection. Clinical Infectious Diseases. 2017. 65: 405-413. PMID: 28369278Year
2017
Journal
Clinical Infectious Diseases
Study
P1043/HPTN 040
Decreased PD-1 Expression on CD8 Lymphocyte Subsets and Increase in CD8Tscm Cells in Children with HIV Receiving Raltegravir
Citation
NB Tustin, JB Murray, R Tustin 3rd, LA Schankel, A Wiznia, S Nachman, SD Douglas, F Tuluc, S Spitsin. Decreased PD-1 Expression on CD8 Lymphocyte Subsets and Increase in CD8Tscm Cells in Children with HIV Receiving Raltegravir. AIDS Research and Human Retroviruses. 2017. 33: 133-142. PMID: 27615375Year
2017
Journal
AIDS Research and Human Retroviruses
Study
P1066
CYP2B6 genotype-directed dosing is required for optimal efavirenz exposure in children 3-36 months with HIV infection
Citation
P Samson, M Bwakura-Dangarembizi, P Jean-Philippe, C Worrell, B Heckman, L Purdue, SA Spector, A Benns, W Borkowsky, A Loftis, E Hawkins, C Wallis, EG Chadwick, IMPAACT P1070 team, C Bolton Moore, EV Capparelli. CYP2B6 genotype-directed dosing is required for optimal efavirenz exposure in children 3-36 months with HIV infection. AIDS. 2017. 31: 1129-1136. PMID: 28323755Year
2017
Journal
AIDS
Study
P1070
Association Between Breast Milk Bacterial Communities and Establishment and Development of the Infant Gut Microbiome.
Citation
JM Bender, S Yang, A Rollie, H Adisetiyo, S Zabih, PJ LIncez, K Bittinger, A Bailey, FD Bushman, JW Sleaseman, GM Aldrovandi, PS Pannarai, F Li. Association Between Breast Milk Bacterial Communities and Establishment and Development of the Infant Gut Microbiome.. The Journal of the American Medical Association. 2017. 1: 647-654. PMID: 28492938Year
2017
Journal
The Journal of the American Medical Association
Concomitant nevirapine impacts pharmacokinetic exposure to the antimalarial artemether-lumefantrine in African children
Citation
JC Lindsey, F Marzan, D Gingrich, B Graham, L Barlow-Mosha, PK Ssemambo, P Kamthunzi, S Nachman, S Parikh, FT Aweeka, IMPAACT P1079 team, L Huang, V Carey. Concomitant nevirapine impacts pharmacokinetic exposure to the antimalarial artemether-lumefantrine in African children. PLoS One. 2017. 12: e0186589. PMID: 29065172Year
2017
Journal
PLoS One
Study
P1079
Delivery After 40 Weeks of Gestation in Pregnant Women With Well-Controlled Human Immunodeficiency Virus
Citation
Margaret M Burke, Rachel A Cohen, Regis Kreitchmann, Rachel K Scott, Nahida Chakhtoura. Delivery After 40 Weeks of Gestation in Pregnant Women With Well-Controlled Human Immunodeficiency Virus. Obstetrics and Gynecology. 2017. 130: 502-510. PMID: 28796679Year
2017
Journal
Obstetrics and Gynecology
Study
P1025
HIV exposed infants vaccinated with a MF59/rgp120 vaccine have higher magnitude anti-V1V2 IgG responses than adults immunized with the same vaccine.
Citation
C Toote, CK Cunningham, EJ McFarland, W Borkowsky, S Barnett, HL Itell, A Kumar, G Gray, MJ McElrath, GD Tomaras, SR Permar, GG Fouda, EP McGuire, Y Fong. HIV exposed infants vaccinated with a MF59/rgp120 vaccine have higher magnitude anti-V1V2 IgG responses than adults immunized with the same vaccine.. Journal of Virology. 2017. 92: e01070-17. PMID: 29021402Year
2017
Journal
Journal of Virology
Missed Opportunities for Prevention of Mother-to-Child Transmission of Human Immunodeficiency Virus
Citation
Daniel Muenz, Alice M. Stek, Jennifer S. Read, IMPAACT P1025 Study Team, Gwendolyn B. Scott, Susan B. Brogly. Missed Opportunities for Prevention of Mother-to-Child Transmission of Human Immunodeficiency Virus. Obstetrics and Gynecology. 2017. 129: 621-628. PMID: 28277349Year
2017
Journal
Obstetrics and Gynecology
Study
P1025